109 related articles for article (PubMed ID: 21084806)
21. [Advanced non-small cell lung cancer responded to both vinorelbine and carboplatin over long-term outpatient treatment].
Chohnabayashi N; Uchiyama N; Nishimura N; Nasu H
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1395-8. PubMed ID: 15446564
[TBL] [Abstract][Full Text] [Related]
22. Cyclophosphamide-cisplatin versus cyclophosphamide-carboplatin in stage III-IV ovarian carcinoma: a comparison of equally myelosuppressive regimens.
Edmonson JH; McCormack GM; Wieand HS; Kugler JW; Krook JE; Stanhope CR; Everson LK; Laurie JA; Ebbert LP; Malkasian GD
J Natl Cancer Inst; 1989 Oct; 81(19):1500-4. PubMed ID: 2674460
[TBL] [Abstract][Full Text] [Related]
23. [Combination chemotherapy of carboplatin and docetaxel for advanced non-small cell lung cancer (NSCLC)].
Bando H; Miyata J; Sano T; Sumitomo M
Gan To Kagaku Ryoho; 2001 Jul; 28(7):947-52. PubMed ID: 11478143
[TBL] [Abstract][Full Text] [Related]
24. A retrospective comparison of adjuvant chemotherapeutic regimens for non-small cell lung cancer (NSCLC): paclitaxel plus carboplatin versus vinorelbine plus cisplatin.
Chang WJ; Sun JM; Lee JY; Ahn JS; Ahn MJ; Park K
Lung Cancer; 2014 Apr; 84(1):51-5. PubMed ID: 24521819
[TBL] [Abstract][Full Text] [Related]
25. [Clinical experience of the use of pemetrexed (PEM) combined with cisplatin (CDDP)/Carboplatin (CBDCA) followed by long-term maintenance PEM in patients with non-squamous non-small cell lung cancer].
Ishikura H; Kumihashi Y; Kimura S; Matsuoka Y; Matsumoto D
Gan To Kagaku Ryoho; 2014 May; 41(5):623-6. PubMed ID: 24917009
[TBL] [Abstract][Full Text] [Related]
26. The cost-effectiveness of paclitaxel (Taxol) + cisplatin is similar to that of teniposide + cisplatin in advanced non-small cell lung cancer: a multicountry analysis.
Annemans L; Giaccone G; Vergnenègre A
Anticancer Drugs; 1999 Jul; 10(6):605-15. PubMed ID: 10885909
[TBL] [Abstract][Full Text] [Related]
27. Carboplatin plus Weekly Paclitaxel with Bevacizumab for First-line Treatment of Non-small Cell Lung Cancer.
Kubota T; Okano Y; Sakai M; Takaoka M; Tsukuda T; Anabuki K; Kawase S; Miyamoto S; Ohnishi H; Hatakeyama N; Machida H; Urata T; Yamamoto A; Ogushi F; Yokoyama A
Anticancer Res; 2016 Jan; 36(1):307-12. PubMed ID: 26722058
[TBL] [Abstract][Full Text] [Related]
28. First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale.
Gebbia V; Lorusso V; Galetta D; Caruso M M; Palomba G; Riccardi F; Borsellino N; Carrozza F; Leo S; Ferraù F; Cinieri S; Mancuso G; Mancarella S; Colucci G
Lung Cancer; 2010 Aug; 69(2):218-24. PubMed ID: 19910076
[TBL] [Abstract][Full Text] [Related]
29. Carboplatin plus either docetaxel or paclitaxel for Japanese patients with advanced non-small cell lung cancer.
Kawahara M; Atagi S; Komuta K; Yoshioka H; Kawasaki M; Fujita Y; Yonei T; Ogushi F; Kubota K; Nogami N; Tsuchiya M; Shibata K; Tomizawa Y; Minato K; Fukuoka K; Asami K; Yamanaka T;
Anticancer Res; 2013 Oct; 33(10):4631-7. PubMed ID: 24123041
[TBL] [Abstract][Full Text] [Related]
30. Phase II Study of Modified Carboplatin Plus Weekly Nab-Paclitaxel in Elderly Patients with Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301.
Miyauchi E; Inoue A; Usui K; Sugawara S; Maemondo M; Saito H; Fujita Y; Kato T; Suzuki T; Harada T; Watanabe H; Nakagawa T; Ichinose M
Oncologist; 2017 Jun; 22(6):640-e59. PubMed ID: 28526722
[TBL] [Abstract][Full Text] [Related]
31. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
[TBL] [Abstract][Full Text] [Related]
32. Docetaxel combination produces 2-year survival advantage in NSCLC patients.
Oncology (Williston Park); 2001 Dec; 15(12):1559, 1564. PubMed ID: 11780700
[No Abstract] [Full Text] [Related]
33. A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.
Klastersky J; Sculier JP; Lacroix H; Dabouis G; Bureau G; Libert P; Richez M; Ravez P; Vandermoten G; Thiriaux J
J Clin Oncol; 1990 Sep; 8(9):1556-62. PubMed ID: 2167953
[TBL] [Abstract][Full Text] [Related]
34. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G;
Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
[TBL] [Abstract][Full Text] [Related]
35. Rates of guideline adherence among US community oncologists treating NSCLC.
Wang Z; Askamit I; Tuscher L; Bergstrom K
Am J Manag Care; 2013; 19(3):185-92. PubMed ID: 23544766
[TBL] [Abstract][Full Text] [Related]
36. Carboplatin plus pemetrexed offers superior cost-effectiveness compared to pemetrexed in patients with advanced non-small cell lung cancer and performance status 2.
Schluckebier L; Garay OU; Zukin M; Ferreira CG
Lung Cancer; 2015 Sep; 89(3):274-9. PubMed ID: 26143106
[TBL] [Abstract][Full Text] [Related]
37. Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance status: results of two Phase II, multicenter trials.
Marsland TA; Garfield DH; Khan MM; Look RM; Boehm KA; Asmar L
Lung Cancer; 2005 Jan; 47(1):111-20. PubMed ID: 15603861
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of first-line induction and maintenance treatment sequences in non-squamous non-small cell lung cancer (NSCLC) in the U.S.
Kumar G; Woods B; Hess LM; Treat J; Boye ME; Bryden P; Winfree KB
Lung Cancer; 2015 Sep; 89(3):294-300. PubMed ID: 26122345
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy for advanced non-small cell lung cancer: past, present, and future.
Ramanathan RK; Belani CP
Semin Oncol; 1997 Aug; 24(4):440-54. PubMed ID: 9280224
[TBL] [Abstract][Full Text] [Related]
40. New options in the treatment of non-small cell lung cancer.
Fossella F; Rigas JR; Belani CP
Anticancer Drugs; 1999 Nov; 10 Suppl 1():S25-8. PubMed ID: 10630365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
